The switch, adenosine A2A
As enzymes in the tissue break the fragments down, they release adenosine and related nucleosides. These bind the adenosine A2A receptor, which sits on the surface of fibroblasts, keratinocytes, blood-vessel cells and immune cells. Activating A2A does three things that matter for skin: it turns down inflammatory signalling, it stimulates fibroblasts to make collagen and to migrate into areas that need repair, and it promotes the growth of small blood vessels through VEGF. In short, it flips tissue from a stressed, inflamed state into a repair state. Laboratory work that blocks the A2A receptor removes most of PDRN’s effect, which is how we know this is the main mechanism rather than a guess.